Thrombo-embolic complications related to hormone therapy of breast cancer - a case report
Journal Title: OncoReview - Year 2013, Vol 3, Issue 1
Abstract
69-year old female with breast cancer treated with surgery (total mastectomy) and cheamo- and radiotherapy, with cancer in right breast operated last year, with further hormone therapy with tamoxifen, suffered from low risk pulmonary embolism. She was treated with streptokinase which was complicated by intracerebral bleeding. The patient was referred to the neurosurgeon and conservative treatment was ordered. Than she was transferred to Department of Pulmonary Circulation and Thromboembolic Diseases, ECZ Otwock where vena cava filter was implanted as prevention of recurrence pulmonary embolism. Progression of deep venous thrombosis associated with thrombosis in vena cava filter and the ”resistance” to treatment using enoxaparin was observed. The inclusion of unfractionated heparin in continuous intravenous infusion, withdrawal of tamoxifen and intensification diuretic therapy has improved patient’s status and allowed discharge from hospital.
Authors and Affiliations
Szymon Darocha, Sebastian Szmit, Łukasz Kownacki, Marcin Kurzyna
Keywords
Related Articles
- EP ID EP53208
- DOI -
- Views 213
- Downloads 0
Powikłania zakrzepowo-zatorowe podczas hormonoterapii raka piersi - opis przypadku
69-letnia otyła kobieta po przebytej mastektomii lewostronnej i operacji oszczędzającej prawej piersi z powodu raka piersi, po przebytej chemio- i radioterapii, w trakcie uzupełniającej hormonoterapii przy użyciu tamoksy...
Report from the ESMO Conference on Sarcoma and GIST, 9–10 March 2012, Milan, Italy
In 9–10 March 2012, Milan (Italy), the conference organized by the European Society for Medical Oncology (ESMO) took place. The main topic of the conference was sarcomas and gastrointestinal stromal tumors (GIST). This c...
Complications of palliative antiangiogenic therapy in patients with colorectal cancer
Introduction: Bevacizumab is an antiangiogenic drug used in the therapy of numerous solid tumours including colorectal adenocarcinoma. The efficacy and safety of bevacizumab has been demonstrated in many multicenter clin...
Liposomal doxorubicin in first line metastatic HER-2-positive breast cancer for prevention the cardiotoxicity
We describe a 62 year old female with metastatic HER-2-positive breast cancer, and with independent cardiovascular comorbidities. She was earlier treated with J131 therapy due to thyroid toxicity. She developed grade 2 m...
Invasive fungal infection in a child with Ewing’s sarcoma
Invasive fungal infection (IFI) in patients with malignant solid tumours is rare, but it highly increases the risk of cancer recurrence because of prolonged discontinuation of cancer treatment. This paper presents a case...